#CLASSYS 214150 | Stock channels

CLASSYS214150

₩28,400+0.89%Close Oct 22

This is the start of #CLASSYS

Talk about CLASSYS here. Pull up price, chart, news and filings just for you from the message box, or mention @InverseOneBot to get an answer everyone can see.

InverseOne BotBOTOnly visible to you

Welcome to the CLASSYS channel. Here's the latest data.

클래시스 214150

Close as of Oct 22

₩28,400+0.89%

Low ₩26,55052-week rangeHigh ₩77,600

At a glance: 4% of the 52-week range, estimated net inflow, lending balance growing, filing check: Quiet.

Disappears when you reload.

클래시스 214150

Close as of Oct 22

₩28,400+0.89%

Low ₩26,55052-week rangeHigh ₩77,600

5 sessions

+4.2%

20 sessions

-9.3%

60 sessions

-35.8%

Volume

0.9x average

Price

Apr 10 ~ Oct 22

₩28,400-47.60%

Low ₩27,250High ₩60,600

Money flow

as of Oct 22

Inflow index+₩39.5M

Net flow, Inflow

Market flow rank: Inflow #3 of 3
Sector flow rank: #1 of 13

Today's overlaps

Near 52w low + inflow index

Multi-day trend, Reversal up

Cumulative flow: +₩140.9M
inflow: 1d streak

Estimated from public price, change and volume. Not actual investor net buying.

as of Oct 22

PER

13.5

PBR

3.37

Market cap

₩1.9T

Lending balance

Building

3,346,612 sh

KRW 0.10T

1D +2.26%5D +2.46%

New 109,672 sh, Returned 35,779 sh

Shares borrowed through securities lending that have not yet been returned. Borrowed shares are often sold afterwards, so the balance is used as a reference for pending sell pressure.

As of 2026-10-22, FSC stock lending data

Filing check

Quiet0 to check first, 0 improvementschecked through Oct 24

This only counts facts confirmed in filings. It does not look at whether the price is cheap or expensive, and it is not a reason to buy or sell on its own.

Earnings quality

We read the latest periodic report and check whether profit matches cash, sales match receivables, and profit from the core business matches profit from elsewhere. There is no score, only the numbers that diverge beyond a threshold and why they matter.

2026 first half, consolidated statements, filed 2026-08-14

3 numbers diverge beyond the threshold

Net profit and operating cash flow
Check this
Net profit 587억 원, operating cash flow 155억 원, 26% of net profit
Cash from operations came in well below net profit. Profit can be booked before the money arrives. Check whether receivables, inventory or contract assets grew as well.
Sales and receivables
Check this
Year on year, sales +20.1%, receivables +100.9%
Receivables 984억 원, a year earlier 490억 원
Receivables grew 80.8pp faster than sales. Collecting payment may be taking longer than before.
Sales and inventory
Check this
Year on year, sales +20.1%, inventory +115.7%
Inventory 649억 원, a year earlier 301억 원
Inventory grew 95.6pp faster than sales. Goods may be piling up faster than they sell.
Profit from outside the core business
Pretax profit 815억 원, operating profit 811억 원, non-operating result 4억 원
0% of pretax profit came from outside the core business. In the same period last year it was -14%.

Source filing: 2026 first half Report a year earlier

This only checks whether the statement numbers agree with each other. It ignores the share price and is not a reason to buy or sell on its own. See the formula

Sector moves

CLASSYS changed +0.89%. The 13 covered Healthcare stocks in Korean averaged -2.68%, with estimated sector flow of outflow.

Variables to watch Drug approvals and trial results, Drug pricing policy, US interest rates, USD/KRW

Risks to check -63% below the high, the downtrend may continue, Clinical trial failure, Drug pricing pressure

Same-sector channels

Latest news

Stock page

Posts are members' opinions. Investment decisions and their consequences are your own.

Data: KRX daily bars, InverseOne quote snapshots, public news feeds, DART filings, InverseOne company research. Not a call to buy or sell.